Cited by 8Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsAdvanced Neuroimaging Techniques and Applications

Apolipoprotein E homozygous ε4 allele status: Effects on cortical structure and white matter integrity in a young to mid-age sample

Goltermann, Janik, Repple, Jonathan, Redlich, Ronny, Dohm, Katharina, Flint, Claas, Grotegerd, Dominik, Waltemate, Lena, Lemke, Hannah +23 more·2021·European Neuropsychopharmacology

Abstract

Apolipoprotein E (APOE) genotype is the strongest single gene predictor of Alzheimer's disease (AD) and has been frequently associated with AD-related brain structural alterations before the onset of dementia. While previous research has primarily focused on hippocampal morphometry in relation to APOE, sporadic recent findings have questioned the specificity of the hippocampus and instead suggested more global effects on the brain. With the present study we aimed to investigate associations between homozygous APOE ε4 status and cortical gray matter structure as well as white matter microstructure. In our study, we contrasted n = 31 homozygous APOE ε4 carriers (age=34.47 years, including a subsample of n = 12 subjects with depression) with a demographically matched sample without an ε4 allele (resulting total sample: N = 62). Morphometry analyses included a) Freesurfer based cortical segmentations of thickness and surface area measures and b) tract based spatial statistics of DTI measures. We found pronounced and widespread reductions in cortical surface area of ε4 homozygotes in 57 out of 68 cortical brain regions. In contrast, no differences in cortical thickness were observed. Furthermore, APOE ε4 homozygous carriers showed significantly lower fractional anisotropy in the corpus callosum, the right internal and external capsule, the left corona radiata and the right fornix. The present findings support a global rather than regionally specific effect of homozygous APOE ε4 allele status on cortical surface area and white matter microstructure. Future studies should aim to delineate the clinical implications of these findings.

Integrity signals

Registry

Crossref · 10.1016/j.euroneuro.2021.02.006

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • White matter and myelin pathology are frequently observed in healthy APOE4 carriers and early Alzheimer's disease subjects.

    “White matter (WM) and myelin pathology are frequently observed in healthy APOE4 carriers and early AD subjects, but the underlying cellular mechanism is obscure.”
  • Independent clinical studies commonly report that early white matter abnormalities occur in healthy APOE4 carriers in the absence of plaque or cognitive impairments.

    “Independent clinical studies reported in common that early WM abnormalities occurs in healthy APOE4 carriers in the absence of plaque or cognitive impairments (Goltermann et al. 2021;Mole et al. 2020;Operto et al. 2018;Bartzokis et al. 2001;Bartzokis et al. 2003;Bartzokis et al. 2007;Bartzokis et al. 2010;Triebswetter et al. 2022).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Goltermann, J., Repple, J., Redlich, R., Dohm, K., Flint, C., Grotegerd, D., Waltemate, L., Lemke, H., Fingas, S. M., Meinert, S., Enneking, V., Hahn, T., Bauer, J., Schmitt, S., Meller, T., Stein, F., Brosch, K., Steinsträter, O., Jansen, A., Krug, A., Nenadić, I., Baune, B. T., Rietschel, M., Witt, S., Forstner, A. J., Nöthen, M., Johnen, A., Alferink, J., Kircher, T., Dannlowski, U., & Opel, N.
Affiliations
  • University of Münster (DE)
  • Philipps University of Marburg (DE)
  • The University of Melbourne (AU)
  • Heidelberg University (DE)
  • University of Bonn (DE)
Venue
European Neuropsychopharmacology
Publisher
Elsevier BV
Published
2021-05
Volume
46
Pages
93-104
ISSN
0924-977X (ISSN-L)
OpenAlex
W3134493953
Cited by
8
References
6
Citations by year
2026: 1 · 2025: 1 · 2024: 4 · 2023: 1 · 2022: 1
FWCI
1.08
Type
journal article
Language
en
Open access
closed
Locations
  • European Neuropsychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
  • Publikationen an der Universität Bielefeld (Universität Bielefeld) (submittedVersion)
  • UWA Profiles and Research Repository (UWA) (submittedVersion)
Funders
Deutsche Forschungsgemeinschaft (DA 1151/5–1, DA 1151/5–2, FOR2107, KI 588/14–1, KI 588/14–2, KO 4291/3–1, KR 3822/5–1, KR 3822/7–2, NE 2254/1–2)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced Neuroimaging Techniques and Applications
Keywords
apolipoprotein E, Alzheimer's disease risk, cortical surface area, cortical thickness, white matter microstructure, fractional anisotropy, corpus callosum, fornix, internal capsule, external capsule, corona radiata, depression, brain structural changes
MeSH terms
Adult, Alleles, Alzheimer Disease, Apolipoproteins E, Brain, Genotype, Homozygote, Humans, Magnetic Resonance Imaging, Apolipoprotein E4, Diffusion Tensor Imaging, White Matter

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review